BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34072010)

  • 1. Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance.
    Soldevilla B; López-López A; Lens-Pardo A; Carretero-Puche C; Lopez-Gonzalvez A; La Salvia A; Gil-Calderon B; Riesco-Martinez MC; Espinosa-Olarte P; Sarmentero J; Rubio-Cuesta B; Rincón R; Barbas C; Garcia-Carbonero R
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.
    La Salvia A; Lens-Pardo A; López-López A; Carretero-Puche C; Capdevila J; Benavent M; Jiménez-Fonseca P; Castellano D; Alonso T; Teule A; Custodio A; Tafuto S; La Casta A; Spada F; Lopez-Gonzalvez A; Gil-Calderon B; Espinosa-Olarte P; Barbas C; Garcia-Carbonero R; Soldevilla B
    Eur J Endocrinol; 2024 Jan; 190(1):62-74. PubMed ID: 38033321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS.
    Zhang Z; Wu X; Zhou M; Qi J; Zhang R; Li X; Wang C; Ruan C; Han Y
    Front Pharmacol; 2022; 13():845275. PubMed ID: 35685646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Profiling of Plasma Samples from Women with Recurrent Spontaneous Abortion.
    Li X; Yin M; Gu J; Hou Y; Tian F; Sun F
    Med Sci Monit; 2018 Jun; 24():4038-4045. PubMed ID: 29898462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
    More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
    Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted plasma metabolome identifies biomarkers in patients with extracranial arteriovenous malformations.
    Fan X; Gao X; Deng Y; Ma B; Liu J; Zhang Z; Zhang D; Yang Y; Wang C; He B; Nie Q; Ye Z; Liu P; Wen J
    Front Physiol; 2023; 14():1207390. PubMed ID: 37727659
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury.
    Xie Z; Chen E; Ouyang X; Xu X; Ma S; Ji F; Wu D; Zhang S; Zhao Y; Li L
    J Proteome Res; 2019 Jun; 18(6):2514-2524. PubMed ID: 31002254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic Profiling of Aqueous Humor and Plasma in Primary Open Angle Glaucoma Patients Points Towards Novel Diagnostic and Therapeutic Strategy.
    Tang Y; Pan Y; Chen Y; Kong X; Chen J; Zhang H; Tang G; Wu J; Sun X
    Front Pharmacol; 2021; 12():621146. PubMed ID: 33935712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity.
    Song H; Wang L; Liu HL; Wu XB; Wang HS; Liu ZH; Li Y; Diao DC; Chen HL; Peng JS
    Oncol Rep; 2011 Aug; 26(2):431-8. PubMed ID: 21567103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolome-based signature of disease pathology in MS.
    Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
    Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis.
    Xia J; Wishart DS
    Curr Protoc Bioinformatics; 2016 Sep; 55():14.10.1-14.10.91. PubMed ID: 27603023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics.
    Abooshahab R; Hooshmand K; Razavi SA; Gholami M; Sanoie M; Hedayati M
    Front Cell Dev Biol; 2020; 8():385. PubMed ID: 32612989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic Profiling Reveals That 5-Hydroxylysine and 1-Methylnicotinamide Are Metabolic Indicators of Keloid Severity.
    Shan M; Liu H; Hao Y; Song K; Meng T; Feng C; Wang Y; Huang Y
    Front Genet; 2021; 12():804248. PubMed ID: 35222522
    [No Abstract]   [Full Text] [Related]  

  • 17. (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
    Cocco E; Murgia F; Lorefice L; Barberini L; Poddighe S; Frau J; Fenu G; Coghe G; Murru MR; Murru R; Del Carratore F; Atzori L; Marrosu MG
    Neurol Neuroimmunol Neuroinflamm; 2016 Feb; 3(1):e185. PubMed ID: 26740964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases.
    Imperiale A; Poncet G; Addeo P; Ruhland E; Roche C; Battini S; Cicek AE; Chenard MP; Hervieu V; Goichot B; Bachellier P; Walter T; Namer IJ
    Metabolites; 2019 Dec; 9(12):. PubMed ID: 31835679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.